Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts.

Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Kurysheva NI, Zhukotskii AV, Goldman IM.

Peptides. 2001 Jun;22(6):979-94.

PMID:
11390029
2.

Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.

Babizhayev MA, Deyev AI, Yermakova VN, Brikman IV, Bours J.

Drugs R D. 2004;5(3):125-39. Review.

PMID:
15139774
6.

Telomere attrition in lens epithelial cells - a target for N-acetylcarnosine therapy.

Babizhayev MA, Yegorov YE.

Front Biosci (Landmark Ed). 2010 Jun 1;15:934-56. Review.

PMID:
20515735
9.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
10.
12.

[Scheimpflug photography of the lens].

Hockwin O.

Fortschr Ophthalmol. 1989;86(4):304-11. Review. German.

PMID:
2676791
13.

Designation of imidazole-containing dipeptides as pharmacological chaperones.

Babizhayev MA.

Hum Exp Toxicol. 2011 Jul;30(7):736-61. doi: 10.1177/0960327110377526. Epub 2010 Jul 23. Review.

PMID:
20656726
14.

The antioxidative properties of carnosine, a natural histidine containing dipeptide.

Boldyrev AA, Dupin AM, Bunin AYa, Babizhaev MA, Severin SE.

Biochem Int. 1987 Dec;15(6):1105-13. Review.

PMID:
3326603
15.

Drugs designed to maintain the transparence of the ocular lens.

Chanalet L, Lapalus P.

Fundam Clin Pharmacol. 1994;8(4):322-41. Review.

PMID:
7851838
16.

Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.

Abdelkader H, Alany RG, Pierscionek B.

J Pharm Pharmacol. 2015 Apr;67(4):537-50. doi: 10.1111/jphp.12355. Epub 2015 Feb 3. Review.

PMID:
25643848

Supplemental Content

Support Center